Public Release: 

Two Douglas Institute researchers named in the Quebec Science list of top 10 discoveries

Douglas Mental Health University Institute

IMAGE?

IMAGE: This is Judes Poirier of the Douglas Institute. view more

Credit: Douglas Institute

Montreal, January 2, 2015 - The Douglas Mental Health University Institute is proud to announce that discoveries by two of its researchers are included on the Québec Science list of the top 10 discoveries of 2014. The announcement of this prestigious list, determined by a jury of journalists and scientists, has become a tradition in the scientific world. Each year, it recognizes the most innovative and promising discoveries, and this year, the efforts of Judes Poirier, Ph.D., C.Q., and Gustavo Turecki, M.D., Ph.D., have drawn particular attention.

A recap of their discoveries:

Judes Poirier - July 2014

New hope for the treatment of Alzheimer's disease

A genetic variant conveys significant protection

Dr. Poirier and his team discovered that a relatively frequent genetic variant actually conveys significant protection against the most common form of Alzheimer's disease and can delay the onset of the disease by as many as four years. This discovery opens new avenues for treatment against this devastating disease.

Dr. Poirier, whose work has been noted on the top 10 list in the past, expressed his appreciation for the recognition: "What a wonderful vote of confidence and honour this is for Quebec-based research into diseases of the brain," he stated.

Gustavo Turecki - June 2014

A tiny molecule may help battle depression

Researchers find a small molecule that predicts treatment response for depressed patients

Levels of a small molecule found only in humans and other primates are lower in the brains of depressed individuals, according to researchers at McGill University and the Douglas Institute. This discovery may hold a key to improving treatment options for those who suffer from depression.

The study, published in the journal Nature Medicine, explains that Dr. Gustavo Turecki and his team of researchers have discovered that the levels of a tiny molecule, miR-1202, may provide a marker for depression and help detect individuals who are likely to respond to antidepressant treatment.

To consult the Québec Science 2014 top 10 list, please visit http://www.quebecscience.qc.ca/accueil.

###

For information and interviews:

Florence Meney
Media relations
Communications and Public Affairs Directorate
Douglas Mental Health University Institute
Dobell Pavilion, Suite B-2122
6875 Boulevard LaSalle
Montreal, Quebec H4H 1R3
Tel.: 514-761-6131, ext. 2769
Florence.meney@douglas.mcgill.ca

About the Douglas Institute

The Douglas is a world-class institute affiliated with McGill University and the World Health Organization. It treats people suffering from mental illness and offers them both hope and healing. Its teams of specialists and researchers are constantly increasing scientific knowledge, integrating this knowledge into patient care, and sharing it with the community in order to educate the public and eliminate prejudices surrounding mental health.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.